BlackRock Inc. - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,301,949
+36.2%
1,680,449
+33.0%
0.00%
Q2 2023$3,158,634
-0.7%
1,263,453
-16.6%
0.00%
Q1 2023$3,181,604
+35.6%
1,515,050
+0.1%
0.00%
Q4 2022$2,346,616
-49.2%
1,513,946
+0.0%
0.00%
Q3 2022$4,617,000
-3.1%
1,513,815
-0.1%
0.00%
Q2 2022$4,765,000
+12.0%
1,514,964
-0.3%
0.00%
Q1 2022$4,254,000
-36.9%
1,519,188
+1.4%
0.00%
Q4 2021$6,744,000
-46.1%
1,498,538
-0.1%
0.00%
Q3 2021$12,515,0001,500,5770.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders